Patton Fund Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-314
Closed -$212K 501
2025
Q4
$212K Sell
314
-188
-37% -$128K 0.03% 445
2025
Q3
$321K Hold
502
0.06% 96
2025
Q2
$269K Buy
+502
New +$240K 0.06% 120
2021
Q4
Sell
-3,080
Closed -$1.92M 99
2021
Q3
$1.92M Sell
3,080
-46
-1% -$30.9K 0.73% 40
2021
Q2
$1.97M Buy
3,126
+209
+7% +$115K 1.04% 19
2021
Q1
$1.43M Sell
2,917
-1,650
-36% -$827K 0.76% 36
2020
Q4
$2.28M Buy
+4,567
New +$2.04M 1.15% 17

Other funds holding IDXX

Patton Fund Management's IDXX Position: Q1 2026 in Review

Patton Fund Management sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 314 shares — an estimated $212K sold.

Patton Fund Management first reported a position in IDXX in Q4 2020 and held it in 7 quarters. The position peaked at $2.28M in Q4 2020. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Patton Fund Management reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
  • Patton Fund Management sold 314 Idexx Laboratories shares in Q1 2026, an estimated $212K.
  • Patton Fund Management first reported a position in Idexx Laboratories in Q4 2020 and held it in 7 quarters.
  • Patton Fund Management's Idexx Laboratories position peaked at $2.28M in Q4 2020.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Patton Fund Management's 13F filing for Q1 2026, filed 22 Apr 2026.